(Q43034296)

12 November 2017

title

Comparison of insulin lispro protamine suspension and insulin detemir in basal-bolus therapy in patients with Type 1 diabetes (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

A R Chacra

1

1 reference

12 November 2017

M Kipnes

2

1 reference

12 November 2017

L L Ilag

3

1 reference

12 November 2017

S Sarwat

4

1 reference

12 November 2017

J Giaconia

5

1 reference

12 November 2017

J Chan

6

1 reference

12 November 2017

COMPLETE T1D investigators

7

1 reference

12 November 2017

language of work or name

1 reference

1 May 2010

1 reference

12 November 2017

1 reference

12 November 2017

volume

27

1 reference

12 November 2017

issue

5

1 reference

12 November 2017

page(s)

563-569

1 reference

Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs.

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.02986.X

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.02986.X

Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.02986.X

Comparison of once- versus twice-daily administration of insulin detemir, used with mealtime insulin aspart, in basal-bolus therapy for type 1 diabetes: assessment of detemir administration in a progressive treat-to-target trial (ADAPT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.02986.X

Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.02986.X

Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.02986.X

Impact of prandial plus basal vs basal insulin on glycemic variability in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.02986.X

Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.02986.X

Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.02986.X

Comparison of three multiple injection regimens for Type 1 diabetes: morning plus dinner or bedtime administration of insulin detemir vs. morning plus bedtime NPH insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.02986.X

Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.02986.X

Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.02986.X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.02986.X

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.02986.X

Higher dose requirements with insulin detemir in type 2 diabetes--three cases and a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.02986.X

Comparison of Pharmacokinetics and Dynamics of the Long-Acting Insulin Analogs Glargine and Detemir at Steady State in Type 1 Diabetes: A double-blind, randomized, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2010.02986.X

10.1111/J.1464-5491.2010.02986.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference